# A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)

> **NCT04431687** · PHASE1 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 48 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** CKD 501
- **DRUG:** D759, D150
- **DRUG:** CKD-501, D759, D150

## Key facts

- **NCT ID:** NCT04431687
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-15
- **Primary completion:** 2020-07-24
- **Final completion:** 2020-10-26
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04431687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04431687, "A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04431687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*